SPINK4 modulates inhibition of glycolysis against colorectal cancer progression
Dysregulation of glycolysis is frequently linked to aggressive tumor activity in colorectal cancer (CRC). Although serine peptidase inhibitor, Kazal type 4 (SPINK4) has been linked to CRC, its exact linkage to glycolytic processes and gene expression remains unclear. Differentially expressed genes...
Furkejuvvon:
| Váldodahkkit: | , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2024-05-01
|
| Ráidu: | Biomolecules & Biomedicine |
| Fáttát: | |
| Liŋkkat: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/10338 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|